Free Stock Analysis Report: See The True Value of Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free

NBIX Insider Trading

Insider Ownership Percentage: 4.40%
Insider Buying (Last 12 Months): $39,032,821.44
Insider Selling (Last 12 Months): $46,270,461.65

Neurocrine Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Neurocrine Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neurocrine Biosciences Share Price & Price History

Current Price: $134.18
Price Change: Price Increase of +0.81 (0.61%)
As of 02/23/2024 01:00 AM ET

This chart shows the closing price history over time for NBIX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Free Stock Analysis Report: See The True Value of Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free

Neurocrine Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2024Richard F. PopsDirectorSell15,000$132.47$1,987,050.0029,512View SEC Filing Icon  
2/13/2024Eiry RobertsInsiderSell1,114$132.96$148,117.4423,716View SEC Filing Icon  
2/13/2024Kevin Charles GormanCEOSell2,832$133.02$376,712.64514,596View SEC Filing Icon  
2/13/2024Matt AbernethyCFOSell1,352$132.85$179,613.2031,528View SEC Filing Icon  
2/8/2024David W. BoyerInsiderSell1,328$135.41$179,824.484,895View SEC Filing Icon  
2/8/2024Kevin Charles GormanCEOSell2,274$134.15$305,057.10506,962View SEC Filing Icon  
2/8/2024Matt AbernethyCFOSell980$134.21$131,525.8030,314View SEC Filing Icon  
2/6/2024David W. BoyerInsiderSell456$141.96$64,733.764,894View SEC Filing Icon  
2/6/2024Kevin Charles GormanCEOSell3,040$142.18$432,227.20504,919View SEC Filing Icon  
2/6/2024Matt AbernethyCFOSell1,280$142.19$182,003.2029,434View SEC Filing Icon  
1/31/2024Eiry RobertsInsiderSell1,457$140.79$205,131.0320,832View SEC Filing Icon  
1/31/2024Kevin Charles GormanCEOSell2,707$140.69$380,847.83502,188View SEC Filing Icon  
1/31/2024Matt AbernethyCFOSell1,283$140.72$180,543.7628,284View SEC Filing Icon  
1/22/2024Darin LippoldtInsiderSell10,000$139.86$1,398,600.0035,882View SEC Filing Icon  
1/8/2024Kevin Charles GormanCEOSell105,835$132.44$14,016,787.40499,754View SEC Filing Icon  
1/2/2024Kyle GanoInsiderSell75,000$131.47$9,860,250.00130,250View SEC Filing Icon  
1/2/2024William H. RastetterDirectorSell11,044$131.47$1,451,954.6851,741View SEC Filing Icon  
12/22/2023Eiry RobertsInsiderSell10,000$126.74$1,267,400.0019,521View SEC Filing Icon  
12/12/2023Eiry RobertsInsiderSell13,925$120.30$1,675,177.5029,521View SEC Filing Icon  
12/8/2023Eiry RobertsInsiderSell300$120.10$36,030.0029,521View SEC Filing Icon  
12/6/2023Darin LippoldtInsiderSell20,830$119.86$2,496,683.8035,882View SEC Filing Icon  
12/1/2023Gary A. LyonsDirectorSell5,000$116.77$583,850.00203,697View SEC Filing Icon  
11/29/2023Jude OnyiaInsiderSell2,331$113.57$264,731.6711,732View SEC Filing Icon  
11/27/2023Darin LippoldtInsiderSell10,919$112.27$1,225,876.1335,882View SEC Filing Icon  
10/2/2023David W. BoyerInsiderSell1,437$112.68$161,921.164,894View SEC Filing Icon  
9/12/2023Gary A. LyonsDirectorSell5,000$115.02$575,100.00203,697View SEC Filing Icon  
9/1/2023Gary A. LyonsDirectorSell5,000$110.06$550,300.00203,697View SEC Filing Icon  
9/1/2023Julie CookeInsiderSell824$110.93$91,406.3217,263View SEC Filing Icon  
8/30/2023David W. BoyerInsiderSell2,733$107.60$294,070.803,460View SEC Filing Icon  
8/28/2023Ingrid DelaetInsiderSell1,431$107.52$153,861.125,931View SEC Filing Icon  
8/21/2023Jude OnyiaInsiderSell3,198$107.37$343,369.269,638View SEC Filing Icon  
8/21/2023Kevin Charles GormanCEOSell9,328$107.40$1,001,827.20499,754View SEC Filing Icon  
8/21/2023Matt AbernethyCFOSell2,132$107.39$228,955.4827,131View SEC Filing Icon  
5/1/2023Julie CookeInsiderSell11,397$103.89$1,184,034.3316,169View SEC Filing Icon  
5/1/2023William H. RastetterDirectorSell4,300$101.43$436,149.0042,785View SEC Filing Icon  
4/24/2023Eiry RobertsInsiderSell14,400$103.48$1,490,112.0026,644View SEC Filing Icon  
4/21/2023William H. RastetterDirectorSell6,034$105.04$633,811.3639,460View SEC Filing Icon  
4/19/2023William H. RastetterDirectorSell903$105.00$94,815.0034,729View SEC Filing Icon  
2/23/2023Neurocrine Biosciences IncMajor ShareholderBuy4,395,588$8.88$39,032,821.448,575,316View SEC Filing Icon  
2/8/2023Eric BenevichInsiderSell980$104.12$102,037.6034,381View SEC Filing Icon  
2/8/2023Kevin Charles GormanCEOSell2,274$104.30$237,178.20491,365View SEC Filing Icon  
2/7/2023Matt AbernethyCFOSell26,328$102.40$2,695,987.2024,333View SEC Filing Icon  
2/6/2023Eric BenevichInsiderSell1,280$105.63$135,206.4017,879View SEC Filing Icon  
2/6/2023Kevin Charles GormanCEOSell3,040$105.68$321,267.20468,008View SEC Filing Icon  
1/31/2023Eiry RobertsInsiderSell1,457$109.99$160,255.4326,171View SEC Filing Icon  
1/31/2023Kevin Charles GormanCEOSell2,707$110.08$297,986.56465,278View SEC Filing Icon  
1/31/2023Matt AbernethyCFOSell1,283$109.98$141,104.3421,357View SEC Filing Icon  
1/6/2023Eric BenevichInsiderSell400$125.00$50,000.0015,643View SEC Filing Icon  
1/3/2023Stephen A. SherwinDirectorSell30,000$118.86$3,565,800.0025,055View SEC Filing Icon  
11/30/2022Eric BenevichInsiderSell50,000$125.90$6,295,000.0015,643View SEC Filing Icon  
11/10/2022Eric BenevichInsiderSell100$125.36$12,536.0015,643View SEC Filing Icon  
11/8/2022Eric BenevichInsiderSell24,593$125.33$3,082,240.6915,643View SEC Filing Icon  
11/3/2022Darin LippoldtInsiderSell4,518$125.02$564,840.3629,234View SEC Filing Icon  
11/1/2022Darin LippoldtInsiderSell10,000$120.09$1,200,900.0029,234View SEC Filing Icon  
10/31/2022Gary A. LyonsDirectorSell15,000$114.76$1,721,400.00203,697View SEC Filing Icon  
10/27/2022Darin LippoldtInsiderSell4,923$115.04$566,341.9229,234View SEC Filing Icon  
10/17/2022Eric BenevichInsiderSell4,960$110.82$549,667.2015,643View SEC Filing Icon  
10/4/2022Gary A. LyonsDirectorSell5,000$110.54$552,700.00203,697View SEC Filing Icon  
10/3/2022David W. BoyerInsiderSell1,437$106.59$153,169.834,214View SEC Filing Icon  
8/12/2022Malcolm Lloyd-SmithInsiderSell21,533$105.95$2,281,421.3518,888View SEC Filing Icon  
6/27/2022Julie CookeInsiderSell754$100.00$75,400.0016,918View SEC Filing Icon  
5/9/2022Richard F. PopsDirectorSell15,000$76.30$1,144,500.0029,512View SEC Filing Icon  
4/25/2022Gary A. LyonsDirectorSell15,000$92.76$1,391,400.00208,697View SEC Filing Icon  
4/1/2022William H. RastetterDirectorSell10,728$94.93$1,018,409.0434,022View SEC Filing Icon  
3/22/2022Darin LippoldtInsiderSell8,455$95.05$803,647.75View SEC Filing Icon  
3/18/2022Darin LippoldtInsiderSell300$95.00$28,500.00View SEC Filing Icon  
2/7/2022David W. BoyerInsiderSell240$81.07$19,456.80View SEC Filing Icon  
2/7/2022Kevin Charles GormanCEOSell8,710$80.82$703,942.20View SEC Filing Icon  
2/7/2022Matt AbernethyCFOSell3,310$80.79$267,414.90View SEC Filing Icon  
1/24/2022Stephen A. SherwinDirectorSell15,000$74.43$1,116,450.00View SEC Filing Icon  
1/10/2022Eiry RobertsInsiderSell2,632$74.50$196,084.00View SEC Filing Icon  
1/5/2022Kyle GanoInsiderSell28,266$85.50$2,416,743.00View SEC Filing Icon  
12/1/2021Matt AbernethyCFOSell1,645$82.59$135,860.55View SEC Filing Icon  
10/7/2021Dimitri E. GrigoriadisInsiderSell8,000$104.81$838,480.00View SEC Filing Icon  
10/7/2021Gary A. LyonsDirectorSell5,000$105.06$525,300.00View SEC Filing Icon  
10/4/2021Julie CookeInsiderSell987$101.73$100,407.51View SEC Filing Icon  
8/16/2021Eric BenevichInsiderSell5,628$89.62$504,381.36View SEC Filing Icon  
7/27/2021Malcolm Lloyd-SmithInsiderSell16,709$93.80$1,567,304.2015,801View SEC Filing Icon  
6/10/2021Gary A. LyonsDirectorSell10,000$100.27$1,002,700.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

93.54% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBIX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Neurocrine Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/21/2024American Trust2,680$0.35M0.0%-12.1%0.003%Search for SEC Filing on Google Icon
2/20/2024Quarry LP300$40K0.0%-84.2%0.000%Search for SEC Filing on Google Icon
2/20/2024Aurora Investment Counsel13,726$1.81M1.1%+2.6%0.014%Search for SEC Filing on Google Icon
2/16/2024DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main18,511$2.44M0.0%-9.6%0.019%Search for SEC Filing on Google Icon
2/16/2024Public Employees Retirement System of Ohio44,960$5.92M0.0%+13.8%0.045%Search for SEC Filing on Google Icon
2/15/2024Mercer Global Advisors Inc. ADV5,292$0.70M0.0%+29.9%0.005%Search for SEC Filing on Google Icon
2/15/2024Dodge & Cox1,259,744$165.98M0.1%+489.8%1.266%Search for SEC Filing on Google Icon
2/15/2024Virtus Fund Advisers LLC687$91K0.6%+70.9%0.001%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC2,688$0.35M0.2%-16.7%0.003%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc576,888$76.01M0.0%+28.7%0.580%Search for SEC Filing on Google Icon
2/15/2024Andra AP fonden72,800$9.59M0.5%+33.3%0.073%Search for SEC Filing on Google Icon
2/15/2024Perpetual Ltd6,786$0.89M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.9,710,328$1.28B0.0%+1.6%9.758%Search for SEC Filing on Google Icon
2/15/2024Voloridge Investment Management LLC22,009$2.90M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/15/2024Voya Investment Management LLC134,746$17.75M0.0%-24.5%0.135%Search for SEC Filing on Google Icon
2/15/2024Vident Advisory LLC2,535$0.33M0.0%-5.7%0.003%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC11,480$1.51M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC360,523$47.50M0.0%-1.2%0.362%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD1,476,949$194.60M0.0%+25.2%1.484%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC15,271$2.01M0.1%-4.6%0.015%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC140,116$18.46M2.6%+67.1%0.141%Search for SEC Filing on Google Icon
2/15/2024Gotham Asset Management LLC5,538$0.73M0.0%+9.5%0.006%Search for SEC Filing on Google Icon
2/15/2024Healthcare of Ontario Pension Plan Trust Fund71,000$9.36M0.0%N/A0.071%Search for SEC Filing on Google Icon
2/15/2024Baird Financial Group Inc.25,585$3.37M0.0%-3.2%0.026%Search for SEC Filing on Google Icon
2/15/2024Bayesian Capital Management LP8,653$1.14M0.1%N/A0.009%Search for SEC Filing on Google Icon
2/15/2024Brevan Howard Capital Management LP5,506$0.73M0.0%+181.6%0.006%Search for SEC Filing on Google Icon
2/15/2024Bridgefront Capital LLC2,453$0.32M0.2%N/A0.002%Search for SEC Filing on Google Icon
2/14/2024Pathstone Holdings LLC6,368$0.84M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/14/2024Braidwell LP715,209$94.24M3.5%-26.1%0.719%Search for SEC Filing on Google Icon
2/14/2024Point72 Asset Management L.P.1,391,970$183.41M0.4%-46.0%1.399%Search for SEC Filing on Google Icon
2/14/2024Creative Planning9,714$1.28M0.0%+17.6%0.010%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC27,843$3.67M0.0%-75.3%0.028%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP658,000$86.70M3.2%+0.9%0.661%Search for SEC Filing on Google Icon
2/14/2024First Financial Bankshares Inc15,802$2.08M0.1%N/A0.016%Search for SEC Filing on Google Icon
2/14/2024Ethic Inc.4,456$0.59M0.0%+22.2%0.004%Search for SEC Filing on Google Icon
2/14/2024Bridgewater Associates LP23,505$3.10M0.0%-57.3%0.024%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP29,346$3.87M2.8%N/A0.029%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG2,430,500$320.24M4.9%-5.9%2.442%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.219,826$28.96M0.1%-58.4%0.221%Search for SEC Filing on Google Icon
2/14/2024Cresset Asset Management LLC3,553$0.47M0.0%+2.9%0.004%Search for SEC Filing on Google Icon
2/14/2024State of Tennessee Treasury Department46,992$6.19M0.0%-10.0%0.047%Search for SEC Filing on Google Icon
2/14/2024Verition Fund Management LLC1,897$0.25M0.0%-95.3%0.002%Search for SEC Filing on Google Icon
2/14/2024Sei Investments Co.115,958$15.28M0.0%+28.1%0.117%Search for SEC Filing on Google Icon
2/14/2024Shell Asset Management Co.2,933$0.39M0.0%-18.8%0.003%Search for SEC Filing on Google Icon
2/14/2024Ossiam5,376$0.71M0.0%+12.9%0.005%Search for SEC Filing on Google Icon
2/14/2024Scout Investments Inc.261,618$34.47M0.9%-28.5%0.263%Search for SEC Filing on Google Icon
2/14/2024Seven Eight Capital LP7,215$0.95M0.1%N/A0.007%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP800,000$105.41M11.2%N/A0.804%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.4,445$0.59M0.3%+10.2%0.004%Search for SEC Filing on Google Icon
2/14/2024Schroder Investment Management Group75,535$9.95M0.0%+31.1%0.076%Search for SEC Filing on Google Icon
2/14/2024Prudential PLC19,931$2.63M0.0%-3.0%0.020%Search for SEC Filing on Google Icon
2/13/2024Vinva Investment Management Ltd4,801$0.63M0.0%+15.7%0.005%Search for SEC Filing on Google Icon
2/13/2024Envestnet Asset Management Inc.199,586$26.30M0.0%+3.5%0.203%Search for SEC Filing on Google Icon
2/13/2024Stephens Inc. AR6,888$0.91M0.0%+16.1%0.007%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp807,281$106.37M0.0%-4.3%0.822%Search for SEC Filing on Google Icon
2/13/2024American International Group Inc.133,543$17.60M0.1%-3.5%0.136%Search for SEC Filing on Google Icon
2/13/2024Cibc World Markets Corp2,720$0.36M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2024Public Employees Retirement Association of Colorado11,684$1.54M0.0%+67.3%0.012%Search for SEC Filing on Google Icon
2/13/20241832 Asset Management L.P.41,000$5.40M0.0%N/A0.042%Search for SEC Filing on Google Icon
2/13/2024Oppenheimer & Co. Inc.17,169$2.26M0.0%+1.5%0.017%Search for SEC Filing on Google Icon
2/13/2024Crossmark Global Holdings Inc.8,056$1.06M0.0%-5.7%0.008%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 14,153$1.87M0.0%+36.8%0.014%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC1,048,000$138.08M1.9%-13.8%1.067%Search for SEC Filing on Google Icon
2/13/2024Eisler Capital UK Ltd.6,843$0.90M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC10,000$1.32M0.2%N/A0.010%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP590,725$77.83M0.1%+27.4%0.601%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.691,632$91.13M0.0%-12.1%0.704%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC76,549$10.09M0.0%-6.1%0.078%Search for SEC Filing on Google Icon
2/13/2024Rhenman & Partners Asset Management AB62,000$8.17M0.8%+13.6%0.063%Search for SEC Filing on Google Icon
2/13/2024CIBC Asset Management Inc3,240$0.43M0.0%-6.6%0.003%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 116,955$15.41M0.0%+18.3%0.119%Search for SEC Filing on Google Icon
2/13/2024KBC Group NV10,582$1.39M0.0%-64.5%0.011%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC2,239$0.30M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/13/2024APG Asset Management US Inc.18,534$2.44M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System144,731$19.07M0.0%-0.6%0.147%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.728,353$95.97M0.5%+0.1%0.741%Search for SEC Filing on Google Icon
2/12/2024Bank of Nova Scotia8,216$1.08M0.0%+27.8%0.008%Search for SEC Filing on Google Icon
2/12/2024Claret Asset Management Corp1,565$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC2,394$0.32M0.0%-28.5%0.002%Search for SEC Filing on Google Icon
2/12/2024TFO Wealth Partners LLC3,180$0.40M0.0%+105,900.0%0.003%Search for SEC Filing on Google Icon
2/12/2024Treasurer of the State of North Carolina68,819$9.07M0.0%+0.8%0.070%Search for SEC Filing on Google Icon
2/12/2024Weiss Asset Management LP14,496$1.91M0.1%N/A0.015%Search for SEC Filing on Google Icon
2/12/2024Allianz Asset Management GmbH29,608$3.90M0.0%-63.9%0.030%Search for SEC Filing on Google Icon
2/12/2024Stifel Financial Corp18,369$2.42M0.0%-2.3%0.019%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc104,219$13.73M0.0%+87.1%0.106%Search for SEC Filing on Google Icon
2/12/2024Parallel Advisors LLC1,536$0.20M0.0%-16.7%0.002%Search for SEC Filing on Google Icon
2/12/2024DSM Capital Partners LLC1,222,009$161.01M2.5%-0.2%1.244%Search for SEC Filing on Google Icon
2/12/2024Hsbc Holdings PLC103,956$13.72M0.0%+33.3%0.106%Search for SEC Filing on Google Icon
2/9/2024Intech Investment Management LLC12,265$1.62M0.0%-30.3%0.012%Search for SEC Filing on Google Icon
2/9/2024Westfield Capital Management Co. LP594,437$78.32M0.5%-8.4%0.605%Search for SEC Filing on Google Icon
2/9/2024Primecap Management Co. CA398,323$52.48M0.0%+1.7%0.405%Search for SEC Filing on Google Icon
2/9/2024Nomura Asset Management Co. Ltd.63,605$8.38M0.0%+0.2%0.065%Search for SEC Filing on Google Icon
2/9/2024Orion Portfolio Solutions LLC29,455$3.95M0.0%-8.5%0.030%Search for SEC Filing on Google Icon
2/9/2024Ontario Teachers Pension Plan Board16,663$2.20M0.0%-17.1%0.017%Search for SEC Filing on Google Icon
2/9/2024Assetmark Inc.36,955$4.87M0.0%+30.7%0.038%Search for SEC Filing on Google Icon
2/9/2024CreativeOne Wealth LLC2,223$0.29M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/9/2024GW&K Investment Management LLC535,962$70.62M0.7%-3.4%0.546%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC4,335$0.57M0.1%N/A0.004%Search for SEC Filing on Google Icon
2/9/2024O Neil Global Advisors Inc.1,535$0.20M0.1%-30.2%0.002%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP88,160$11.62M0.3%+1,364.2%0.090%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Neurocrine Biosciences logo
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Read More on Neurocrine Biosciences

Today's Range

Now: $134.18
Low: $132.73
High: $134.65

50 Day Range

MA: $133.59
Low: $119.92
High: $142.96

52 Week Range

Now: $134.18
Low: $89.04
High: $143.35

Volume

542,052 shs

Average Volume

791,964 shs

Market Capitalization

$13.35 billion

P/E Ratio

55.45

Dividend Yield

N/A

Beta

0.25

Who are the company insiders with the largest holdings of Neurocrine Biosciences?

Neurocrine Biosciences' top insider shareholders include:
  1. Neurocrine Biosciences Inc (Major Shareholder)
  2. Kevin Charles Gorman (CEO)
  3. Gary A Lyons (Director)
  4. Kyle Gano (Insider)
  5. William H Rastetter (Director)
  6. Darin Lippoldt (Insider)
  7. Eric Benevich (Insider)
  8. Matt Abernethy (CFO)
  9. Eiry Roberts (Insider)
  10. Richard F Pops (Director)
  11. Stephen A Sherwin (Director)
  12. Malcolm Lloyd-Smith (Insider)
  13. Julie Cooke (Insider)
  14. Jude Onyia (Insider)
  15. Ingrid Delaet (Insider)
  16. David W Boyer (Insider)
Learn More about top insider investors at Neurocrine Biosciences.

Who are the major institutional investors of Neurocrine Biosciences?

Neurocrine Biosciences' top institutional investors include:
  1. Vanguard Group Inc. — 9.76%
  2. Bellevue Group AG — 2.44%
  3. Price T Rowe Associates Inc. MD — 1.48%
  4. Point72 Asset Management L.P. — 1.40%
  5. Dodge & Cox — 1.27%
  6. DSM Capital Partners LLC — 1.24%
Learn More about top institutional investors of Neurocrine Biosciences stock.

Which institutional investors are selling Neurocrine Biosciences stock?

During the previous quarter, NBIX stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. Balyasny Asset Management L.P.
  3. Assenagon Asset Management S.A.
  4. Braidwell LP
  5. Armistice Capital LLC
  6. Bellevue Group AG
  7. Scout Investments Inc.
  8. Goldman Sachs Group Inc.
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
  1. Neurocrine Biosciences Inc (Major Shareholder)
  2. Kevin Charles Gorman (CEO)
  3. Gary A Lyons (Director)
  4. Kyle Gano (Insider)
  5. William H Rastetter (Director)
  6. Darin Lippoldt (Insider)
  7. Eric Benevich (Insider)
  8. Matt Abernethy (CFO)
  9. Eiry Roberts (Insider)
  10. Richard F Pops (Director)
  11. Stephen A Sherwin (Director)
  12. Malcolm Lloyd-Smith (Insider)
Learn More investors selling Neurocrine Biosciences stock.

Which institutional investors are buying Neurocrine Biosciences stock?

Within the previous quarter, NBIX stock was bought by institutional investors including:
  1. Dodge & Cox
  2. Vestal Point Capital LP
  3. Los Angeles Capital Management LLC
  4. Price T Rowe Associates Inc. MD
  5. Norges Bank
  6. Allspring Global Investments Holdings LLC
  7. Vanguard Group Inc.
  8. Legal & General Group Plc
Free Stock Analysis Report: See The True Value of Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free